Autonomic Technologies, Inc. (ATI™) is a medical device company headquartered in the San Francisco Bay Area with offices in Germany and Switzerland, focused on the development and commercialization of innovative therapies for the treatment of autonomic disorders, particularly severe headache. The company's initial product, the Pulsante microstimulator, is CE marked in Europe for the treatment of cluster headache. The device is also under an IDE study in the US for the treatment of chronic cluster headache. For more information, please visit: www.pulsante.eu or www.ati-spg.com.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/12/15 | $38,000,000 | Series D |
Aberdare Ventures Cleveland Clinic Edmond de Rothschild Investment Partners Forbion Capital Partners InterWest Partners Novartis Venture Funds | undisclosed |
| 06/25/15 | $5,500,000 | Series D |
HBM Healthcare Investments | undisclosed |
